In this article SPCE XLRN MRK KMX MKC FUBO Check out the companies making headlines before the bell: CarMax (KMX) – The auto retailer missed estimates by 18 cents with quarterly earnings of $1.72 per share, although revenue topped analyst projections. Comparable pre-owned car sales rose 6.2%, less than the 7.3% estimate of analysts surveyed
Over the nearly two-year trailing period, both the U.S. and the rest of the world have suffered radical changes — so much so that some of the adjustments could be permanent. That specter has put plenty of pressure on investors. But easily one of the most perplexing opportunities right now is in oil stocks. Although
ViacomCBS (NASDAQ:VIAC) stock is a dividend play for viewers as old as its audience. Source: Jer123 / Shutterstock.com The brief burst of the Archegos “scandal” (it wasn’t illegal, just stupid) sent the stock over $90 early this year. But its intrinsic value is where it trades at this writing. That would be about $40. The market
Globalstar (NYSEAMERICAN:GSAT) is a highly speculative global satellite company that is coming off peak speculation. GSAT stock peaked at $2.69 on hopes that Apple (NASDAQ:AAPL) was going to sign up with the company. When that didn’t happen during a recent Sept. 14 conference, the stock started falling. Unfortunately, it probably has much lower to go.
In my last article on Nvidia (NASDAQ:NVDA), I made the argument that the overall market’s direction would determine NVDA stock’s next move. Today, I hold the same view when it comes to a downturn. If correction fears prove true, shares in this fast-growing chip maker will likely move in tandem. Source: Allmy / Shutterstock.com Of
Two Stocks With an Upward Moving Earnings Outlook zacks.com zacks.com/ultimate
Chamath Palihapitiya revealed that he sold his Tesla position for capital to invest in other investment ideas. The Social Capital Founder and CEO said that he exited his bet on the Elon Musk-led electric vehicle company “in the last year or so” as the high prices allowed him to generate cash to fund his other
In this article CAG LLY BA DLTR People walk by a Dollar Tree store on December 11, 2018 in the Brooklyn borough of New York City. Spencer Platt | Getty Images News | Getty Images Check out the companies making headlines in midday trading. Dollar Tree — Dollar Tree surged 16% after the discount retailer
Nvidia’s (NASDAQ:NVDA) core businesses have been firing on all cylinders, and its move into other profitable verticals has resulted in consistent top-line growth. The company’s market value has grown at an incredible pace over the past decade. Yet, NVDA stock still has a ton of upside left with new catalysts that will amplify growth in
Any investment in Ocugen (NASDAQ:OCGN) stock is based on hope. That hope involves the FDA approving the Covid-19 vaccine known as Covaxin. Source: shutterstock.com/PhotobyTawat Over the last six months or so, the company has repeatedly suggested that such an approval was imminent. On Feb. 2, Ocugen announced an agreement with the Indian drug maker
Inter Vivos vs. Testamentary Trusts: An Overview Estate planning offers tools to establish and maintain effective control over cash, investments, and real estate assets during a person’s lifetime and upon death. While wills and beneficiary designations work well to ensure an estate plan meets the unique needs of the individual establishing the plan, each has its
Internet of things (IoT) is a somewhat overused technology buzzword of late, but still has important meaning in the future of everyday life. One recent IPO that may be able to take advantage of this growth market is Focus Universal (NASDAQ:FCUV), which went public on Aug. 31 of this year. 2 million common shares of
ESG investing, or when a company’s environmental, social and governance factors are evaluated, is booming, and a panel of sustainability-focused investors said the trend is only going to accelerate from here. Climate change “is a mega-trend that if you take advantage of it, and get ahead of it, it’s going to be an alpha generator
In this article MU LLY NFLX LCID DLTR ASML-NL Check out the companies making headlines before the bell: Micron Technology (MU) – Micron reported adjusted quarterly earnings of $2.42 per share, 9 cents above estimates, with the chip maker’s revenue also topping Street forecasts. However, its current-quarter forecast fell below consensus, due to computer-making customers
The pandemic forced the world to be out of work for months. This brought about a new wave of retail investors into the trading gig. Robinhood (NASDAQ:HOOD) stock was in the right spot at the right time. They captured much of the newbies and grew at an impressive rate. Source: OpturaDesign / Shutterstock.com There is
When looking for growth potential, there’s a lot to like about many consumer stocks these days. Consumer spending has been on fire so far this year and it looks like the economy is going to continue to perform strongly — despite the disruption of the Delta Covid-19 variant. Each of the companies on this list
A year ago, electric vehicles (EVs) were a promising sector for investors. But in 2021, that all changed. Sponsors of special purpose acquisition companies (SPACs) flooded the market with new EV stock investments. Some of these, like Lucid Motors (NASDAQ:LCID), have worked out pretty well. Most, however, have been terrible for investors. Unfortunately, Lordstown Motors
MoneyWire has always been about hypergrowth investing — focusing on the megatrends, leading companies, and cryptocurrency projects that are changing the world, disrupting gigantic industries, and taking us to a future that used to be only the stuff of science fiction. It is now real, and it is the best way to build generational wealth
Preston Pysh talks with Bitcoin & privacy expert, Matt Odell, about various levels of privacy on Bitcoin’s multiple layers & nodes. Matt also talks about the mining industry and privacy in general. IN THIS EPISODE, YOU’LL LEARN: 00:00:00 – Intro 00:08:55 – How Matt Odell Got Into Bitcoin? 00:13:41 – Why Large Social Media Companies
Increasing M&A deals and cutting edge therapies are driving biotech ETFs higher. IShares Nasdaq Biotechnology ETF: https://www.zacks.com/funds/etf/IBB/profile?cid=CS-YOUTUBE-FT-VID SPDR S&P Biotech ETF: https://www.zacks.com/funds/etf/XBI/profile?cid=CS-YOUTUBE-FT-VID ARK Genomic Revolution ETF: https://www.zacks.com/funds/etf/ARKG/profile?cid=CS-YOUTUBE-FT-VID Virtus LifeSci Biotech Clinical Trials ETF: https://www.zacks.com/funds/etf/BBC/profile?cid=CS-YOUTUBE-FT-VID ALPS Medical Breakthroughs ETF: https://www.zacks.com/funds/etf/SBIO/profile?cid=CS-YOUTUBE-FT-VID Merck: https://www.zacks.com/stock/quote/MRK?cid=CS-YOUTUBE-FT-VID Biogen: https://www.zacks.com/stock/quote/BIIB?cid=CS-YOUTUBE-FT-VID Sanofi: https://www.zacks.com/stock/quote/SNY?cid=CS-YOUTUBE-FT-VID ArQule: https://www.zacks.com/stock/quote/ARQL?cid=CS-YOUTUBE-FT-VID Synthorx: https://www.zacks.com/stock/quote/THOR?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow